Literature DB >> 27984722

An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer.

Lianfeng Wu1, Ben Zhou1, Noriko Oshiro-Rapley2, Man Li3, Joao A Paulo4, Christopher M Webster1, Fan Mou3, Michael C Kacergis5, Michael E Talkowski6, Christopher E Carr7, Steven P Gygi4, Bin Zheng3, Alexander A Soukas8.   

Abstract

Metformin has utility in cancer prevention and treatment, though the mechanisms for these effects remain elusive. Through genetic screening in C. elegans, we uncover two metformin response elements: the nuclear pore complex (NPC) and acyl-CoA dehydrogenase family member-10 (ACAD10). We demonstrate that biguanides inhibit growth by inhibiting mitochondrial respiratory capacity, which restrains transit of the RagA-RagC GTPase heterodimer through the NPC. Nuclear exclusion renders RagC incapable of gaining the GDP-bound state necessary to stimulate mTORC1. Biguanide-induced inactivation of mTORC1 subsequently inhibits growth through transcriptional induction of ACAD10. This ancient metformin response pathway is conserved from worms to humans. Both restricted nuclear pore transit and upregulation of ACAD10 are required for biguanides to reduce viability in melanoma and pancreatic cancer cells, and to extend C. elegans lifespan. This pathway provides a unified mechanism by which metformin kills cancer cells and extends lifespan, and illuminates potential cancer targets. PAPERCLIP.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  ACAD10; C. elegans; Metformin; NPC; RagC GTPase; acyl-CoA dehydrogenase family member 10; cancer; diabetes; growth; lifespan; mTORC1; mechanistic target of rapamycin complex 1; mitochondrial respiratory capacity; nuclear pore complex; nuclear transport

Mesh:

Substances:

Year:  2016        PMID: 27984722      PMCID: PMC5390486          DOI: 10.1016/j.cell.2016.11.055

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

1.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors:  Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

3.  Transient nuclear envelope rupturing during interphase in human cancer cells.

Authors:  Jesse D Vargas; Emily M Hatch; Daniel J Anderson; Martin W Hetzer
Journal:  Nucleus       Date:  2012 Jan-Feb       Impact factor: 4.197

4.  ATP-Induced shape change of nuclear pores visualized with the atomic force microscope.

Authors:  A Rakowska; T Danker; S W Schneider; H Oberleithner
Journal:  J Membr Biol       Date:  1998-05-15       Impact factor: 1.843

5.  Variants in ACAD10 are associated with type 2 diabetes, insulin resistance and lipid oxidation in Pima Indians.

Authors:  L Bian; R L Hanson; Y L Muller; L Ma; S Kobes; W C Knowler; C Bogardus; L J Baier
Journal:  Diabetologia       Date:  2010-07       Impact factor: 10.122

6.  Mitochondrial SKN-1/Nrf mediates a conserved starvation response.

Authors:  Jennifer Paek; Jacqueline Y Lo; Sri Devi Narasimhan; Tammy N Nguyen; Kira Glover-Cutter; Stacey Robida-Stubbs; Takafumi Suzuki; Masayuki Yamamoto; T Keith Blackwell; Sean P Curran
Journal:  Cell Metab       Date:  2012-10-03       Impact factor: 27.287

7.  Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence.

Authors:  Michael J Steinbaugh; Sri Devi Narasimhan; Stacey Robida-Stubbs; Lorenza E Moronetti Mazzeo; Jonathan M Dreyfuss; John M Hourihan; Prashant Raghavan; Theresa N Operaña; Reza Esmaillie; T Keith Blackwell
Journal:  Elife       Date:  2015-08-24       Impact factor: 8.140

8.  Altering nuclear pore complex function impacts longevity and mitochondrial function in S. cerevisiae.

Authors:  Christopher L Lord; Benjamin L Timney; Michael P Rout; Susan R Wente
Journal:  J Cell Biol       Date:  2015-03-16       Impact factor: 10.539

9.  Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.

Authors:  Takla Griss; Emma E Vincent; Robert Egnatchik; Jocelyn Chen; Eric H Ma; Brandon Faubert; Benoit Viollet; Ralph J DeBerardinis; Russell G Jones
Journal:  PLoS Biol       Date:  2015-12-01       Impact factor: 8.029

10.  Regulation of TORC1 by Rag GTPases in nutrient response.

Authors:  Eunjung Kim; Pankuri Goraksha-Hicks; Li Li; Thomas P Neufeld; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

View more
  78 in total

Review 1.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

Review 2.  Metabolic pathways at the crossroads of diabetes and inborn errors.

Authors:  Eric S Goetzman; Zhenwei Gong; Manuel Schiff; Yan Wang; Radhika H Muzumdar
Journal:  J Inherit Metab Dis       Date:  2017-09-26       Impact factor: 4.982

Review 3.  Metformin as an Anticancer Agent.

Authors:  Ales Vancura; Pengli Bu; Madhura Bhagwat; Joey Zeng; Ivana Vancurova
Journal:  Trends Pharmacol Sci       Date:  2018-08-24       Impact factor: 14.819

4.  Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.

Authors:  Ke Li; Ting-Ting Zhang; Feng Wang; Bing Cui; Chen-Xi Zhao; Jiao-Jiao Yu; Xiao-Xi Lv; Xiao-Wei Zhang; Zhao-Na Yang; Bo Huang; Xia Li; Fang Hua; Zhuo-Wei Hu
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

5.  Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans.

Authors:  Lilia Espada; Alexander Dakhovnik; Prerana Chaudhari; Asya Martirosyan; Laura Miek; Tetiana Poliezhaieva; Yvonne Schaub; Ashish Nair; Nadia Döring; Norman Rahnis; Oliver Werz; Andreas Koeberle; Joanna Kirkpatrick; Alessandro Ori; Maria A Ermolaeva
Journal:  Nat Metab       Date:  2020-11-02

Review 6.  TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging.

Authors:  T Keith Blackwell; Aileen K Sewell; Ziyun Wu; Min Han
Journal:  Genetics       Date:  2019-10       Impact factor: 4.562

Review 7.  Metformin and Breast Cancer: Molecular Targets.

Authors:  J Faria; G Negalha; A Azevedo; F Martel
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-03-22       Impact factor: 2.673

Review 8.  Metformin: Mechanisms in Human Obesity and Weight Loss.

Authors:  Armen Yerevanian; Alexander A Soukas
Journal:  Curr Obes Rep       Date:  2019-06

9.  Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.

Authors:  Guohui Qin; Jingyao Lian; Lan Huang; Qitai Zhao; Shasha Liu; Zhen Zhang; Xinfeng Chen; Dongli Yue; Lifeng Li; Feng Li; Lidong Wang; Viktor Umansky; Bin Zhang; Shengli Yang; Yi Zhang
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 10.  Benefits of Metformin in Attenuating the Hallmarks of Aging.

Authors:  Ameya S Kulkarni; Sriram Gubbi; Nir Barzilai
Journal:  Cell Metab       Date:  2020-04-24       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.